PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
02-Oct-2024 Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17 AccessWire
02-Oct-2024 Hemogenyx Pharmaceuticals PLC Announces Strategic Investment from Prevail Partners, LLC AccessWire
02-Oct-2024 Moolec Science Presents Fiscal Year 2024 Annual Business Update AccessWire
01-Oct-2024 Justera Health Signs Definitive Agreement To Acquire Popular Cannabis Brand, Port North AccessWire
01-Oct-2024 Muscle Lab Celebrates Grand Opening of Studio City Location on Ventura Blvd. AccessWire
01-Oct-2024 Legacy ER & Urgent Care Opens Seventh Dual Facility in Prosper, Texas on October 21 AccessWire
01-Oct-2024 BIOLASE Voluntarily Initiates Chapter 11 Proceedings AccessWire
01-Oct-2024 Cascade and Ottobock Announce Ownership Interest Change; an Independent Way Forward in Partnership AccessWire
01-Oct-2024 First Computer Chip in Spine Offers Hope, Opens Door for Injectable Therapies in Chronic Pain, Sleep Apnea, and Migraines AccessWire
01-Oct-2024 Elevate Clinical Research Solutions Announces Senior Director Nicole Bruecker AccessWire
01-Oct-2024 Glidewell Publishes Issue of Chairside(R) Magazine Dedicated to In-Office Digital Dentistry AccessWire
01-Oct-2024 How To Choose Between Veneers and Crowns for Your Cosmetic Needs AccessWire
01-Oct-2024 OccuPro Launches POET 4.0: Revolutionary Upgrade to Post Offer Employment Testing Software AccessWire
01-Oct-2024 Black Book IT Leader Survey Reveals 8 Technologies Draining Value From Health Systems AccessWire
01-Oct-2024 New Report: Investment in Alzheimer’s Research Today Will Yield Health Benefits for the Next Generation of Adults With Down Syndrome AccessWire
01-Oct-2024 Lexaria Appoints Michael Shankman as Chief Financial Officer AccessWire
01-Oct-2024 Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US AccessWire
01-Oct-2024 Jaguar Health Reports Statistically Significant Improvement in Breast Cancer Patients in its Phase 3 OnTarget Trial for its Cancer Supportive Care Drug Crofelemer AccessWire
01-Oct-2024 Innovations in Physiotherapy: Exploring New Technologies and Techniques That Improve Patient Outcomes AccessWire
01-Oct-2024 Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada AccessWire